Clinical trial · Observational
PPK Study Based on Quantitative Pharmacology in Patients With Pamipril
NCT05848648CI-TRIAL-00075842unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a non-intervention, prospective, one-arm, observational real-world clinical trial. The researchers plan to recruit at least 50 qualified patients. The main purpose of this study was to establish a population pharmacokinetic model of Pamiparib and to explore the correlation between its pharmacokinetic parameters and adverse reactions.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Blood drug concentration
- timeFrame
- 6 months
- description
- After treating with Pamipali, blood samples were collected at different time periods
Secondary outcomes (1)
- measure
- Correlation between blood drug concentration and adverse events
- timeFrame
- 6 months
- description
- Try to find the relationship between pharmacokinetic parameters and adverse events
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. The age of the patient is ≥ 18 years old and less than 80 years old. 2. Receive treatment with pamipalil. 3. The patient signed a written informed consent form. Exclusion Criteria: 1. The expected survival time may be less than the treatment cycle. 2. Is being treated with other systemic trial drugs. 3. There are other factors that the researchers think are not suitable for joining the group.
References
Publications (0)
Data not yet available
No reference posted for this study.